Cargando…
Thromboembolic Prophylaxis in Total Joint Arthroplasty
Approximately 775,000 hip and knee arthroplasties are performed yearly in the United States, with a dramatic increase expected. Patients having hip and knee arthroplasties are at high risk of developing a venous thromboembolism. The American College of Chest Physicians (ACCP) and the American Academ...
Autores principales: | Knesek, David, Peterson, Todd C., Markel, David C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458274/ https://www.ncbi.nlm.nih.gov/pubmed/23029611 http://dx.doi.org/10.1155/2012/837896 |
Ejemplares similares
-
Incidence of Heterotopic Ossification in Direct Anterior Approach to Total Hip Arthroplasty with use of Aspirin as Thromboembolic Prophylaxis
por: Knapp, Paul, et al.
Publicado: (2020) -
Statistical Fragility of Venous Thromboembolism Prophylaxis Following Total Joint Arthroplasty
por: Sequeira, Sean B., et al.
Publicado: (2023) -
PROSPECTIVE STUDY OF ASPIRIN FOR THROMBOEMBOLISM PROPHYLAXIS IN TOTAL HIP ARTHROPLASTY
por: LINS, RAUL CARNEIRO, et al.
Publicado: (2018) -
The Efficacy and Safety of Rivaroxaban for Venous Thromboembolism Prophylaxis after Total Hip and Total Knee Arthroplasty
por: Russell, Robert D., et al.
Publicado: (2013) -
Thromboembolism in Arthroplasty: Compliance to Prophylaxis
por: Viana, Leandra Marla Aires Travassos, et al.
Publicado: (2021)